Invasive breast carcinomas in Ghana: high frequency of high grade, basal-like histology and high EZH2 expression

Increased risk for distant metastasis in patients with familial early-stage breast cancer and high EZH2 expression

(2011) Sharon Hensley Alford et al.   BREAST CANCER RESEARCH AND TREATMENT

Polycomb group protein EZH2 is frequently expressed in inflammatory breast cancer and is predictive of worse clinical outcome

(2011) Yun Gong et al.   CANCER

Histone Methyltransferase EZH2 Induces Akt-Dependent Genomic Instability and BRCA1 Inhibition in Breast Cancer

(2011) M. E. Gonzalez et al.   CANCER RESEARCH

Aberrations of EZH2 in Cancer

(2011) A. Chase et al.   CLINICAL CANCER RESEARCH

EZH2 and ALDH-1 mark breast epithelium at risk for breast cancer development

(2011) Lakshmi P Kunju et al.   MODERN PATHOLOGY

African ancestry and higher prevalence of triple-negative breast cancer

(2010) Azadeh Stark et al.   CANCER

Population Differences in Breast Cancer: Survey in Indigenous African Women Reveals Over-Representation of Triple-Negative Breast Cancer

(2009) Dezheng Huo et al.   JOURNAL OF CLINICAL ONCOLOGY

DZNep is a global histone methylation inhibitor that reactivates developmental genes not silenced by DNA methylation

(2009) T. B. Miranda et al.   MOLECULAR CANCER THERAPEUTICS

Basal-Like Breast Cancer: A Critical Review

(2008) Emad A. Rakha et al.   JOURNAL OF CLINICAL ONCOLOGY

Downregulation of EZH2 decreases growth of estrogen receptor-negative invasive breast carcinoma and requires BRCA1

(2008) M E Gonzalez et al.   ONCOGENE